1 Higdon JV, Delage B, Williams DE, et al. (2007) Cruciferous vegetables and human cancer risk: epidemiologic evidence and mechanistic basis. Pharmacol Res 55, 224–236.
2 Zhang Y, Yao S & Li J (2006) Vegetable-derived isothiocyanates: anti-proliferative activity and mechanism of action. Proc Nutr Soc 65, 68–75.
3 Zhang Y (2004) Cancer-preventive isothiocyanates: measurement of human exposure and mechanism of action. Mutat Res 555, 173–190.
4 Brennan P, Hsu CC, Moullan N, et al. (2005) Effect of cruciferous vegetables on lung cancer in patients stratified by genetic status: a mendelian randomisation approach. Lancet 366, 1558–1560.
5 London SJ, Yuan JM, Chung FL, et al. (2000) Isothiocyanates, glutathione S-transferase M1 and T1 polymorphisms, and lung-cancer risk: a prospective study of men in Shanghai, China. Lancet 356, 724–729.
6 Zhao B, Seow A, Lee EJ, et al. (2001) Dietary isothiocyanates, glutathione S-transferase -M1, -T1 polymorphisms and lung cancer risk among Chinese women in Singapore. Cancer Epidemiol Biomarkers Prev 10, 1063–1067.
7 Spitz MR, Duphorne CM, Detry MA, et al. (2000) Dietary intake of isothiocyanates: evidence of a joint effect with glutathione S-transferase polymorphisms in lung cancer risk. Cancer Epidemiol Biomarkers Prev 9, 1017–1020.
8 Steck SE & Hebert JR (2009) GST polymorphism and excretion of heterocyclic aromatic amine and isothiocyanate metabolites after Brassica consumption. Environ Mol Mutagen 50, 238–246.
9 Clarke JD, Dashwood RH & Ho E (2008) Multi-targeted prevention of cancer by sulforaphane. Cancer Lett 269, 291–304.
10 Hecht SS (2000) Inhibition of carcinogenesis by isothiocyanates. Drug Metab Rev 32, 395–411.
11 Zhang Y (2000) Role of glutathione in the accumulation of anticarcinogenic isothiocyanates and their glutathione conjugates by murine hepatoma cells. Carcinogenesis 21, 1175–1182.
12 Xu K & Thornalley PJ (2001) Involvement of glutathione metabolism in the cytotoxicity of the phenethyl isothiocyanate and its cysteine conjugate to human leukaemia cells in vitro. Biochem Pharmacol 61, 165–177.
13 Trachootham D, Zhou Y, Zhang H, et al. (2006) Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by beta-phenylethyl isothiocyanate. Cancer Cell 10, 241–252.
14 Mi L, Wang X, Govind S, et al. (2007) The role of protein binding in induction of apoptosis by phenethyl isothiocyanate and sulforaphane in human non-small lung cancer cells. Cancer Res 67, 6409–6416.
15 Dinkova-Kostova AT, Holtzclaw WD, Cole RN, et al. (2002) Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants. Proc Natl Acad Sci U S A 99, 11908–11913.
16 Keum YS, Owuor ED, Kim BR, et al. (2003) Involvement of Nrf2 and JNK1 in the activation of antioxidant responsive element (ARE) by chemopreventive agent phenethyl isothiocyanate (PEITC). Pharm Res 20, 1351–1356.
17 McMahon M, Itoh K, Yamamoto M, et al. (2003) Keap1-dependent proteasomal degradation of transcription factor Nrf2 contributes to the negative regulation of antioxidant response element-driven gene expression. J Biol Chem 278, 21592–21600.
18 Xu C, Yuan X, Pan Z, et al. (2006) Mechanism of action of isothiocyanates: the induction of ARE-regulated genes is associated with activation of ERK and JNK and the phosphorylation and nuclear translocation of Nrf2. Mol Cancer Ther 5, 1918–1926.
19 Mi L, Xiao Z, Hood BL, et al. (2008) Covalent binding to tubulin by isothiocyanates. A mechanism of cell growth arrest and apoptosis. J Biol Chem 283, 22136–22146.
20 Cross JV, Rady JM, Foss FW, et al. (2009) Nutrient isothiocyanates covalently modify and inhibit the inflammatory cytokine macrophage migration inhibitory factor (MIF). Biochem J 423, 315–321.
21 Brown KK, Blaikie FH, Smith RA, et al. (2009) Direct modification of the pro-inflammatory cytokine MIF by dietary isothiocyanates. J Biol Chem 284, 32425–32433.
22 Cross JV, Foss FW, Rady JM, et al. (2007) The isothiocyanate class of bioactive nutrients covalently inhibit the MEKK1 protein kinase. BMC Cancer 7, 183.
23 Myzak MC, Karplus PA, Chung FL, et al. (2004) A novel mechanism of chemoprotection by sulforaphane: inhibition of histone deacetylase. Cancer Res 64, 5767–5774.
24 Wang XH, Cavell BE, Syed Alwi SS, et al. (2009) Inhibition of hypoxia inducible factor by phenethyl isothiocyanate. Biochem Pharmacol 78, 261–272.
25 Rankin EB & Giaccia AJ (2008) The role of hypoxia-inducible factors in tumorigenesis. Cell Death Differ 15, 678–685.
26 Weidemann A & Johnson RS (2008) Biology of HIF-1alpha. Cell Death Differ 15, 621–627.
27 Xiao D & Singh SV (2007) Phenethyl isothiocyanate inhibits angiogenesis in vitro and ex vivo. Cancer Res 67, 2239–2246.
28 Bertl E, Bartsch H & Gerhauser C (2006) Inhibition of angiogenesis and endothelial cell functions are novel sulforaphane-mediated mechanisms in chemoprevention. Mol Cancer Ther 5, 575–585.
29 Jackson SJ, Singletary KW & Venema RC (2007) Sulforaphane suppresses angiogenesis and disrupts endothelial mitotic progression and microtubule polymerization. Vascul Pharmacol 46, 77–84.
30 Carmeliet P & Jain RK (2000) Angiogenesis in cancer and other diseases. Nature 407, 249–257.
31 Hu J, Straub J, Xiao D, et al. (2007) Phenethyl isothiocyanate, a cancer chemopreventive constituent of cruciferous vegetables, inhibits cap-dependent translation by regulating the level and phosphorylation of 4E-BP1. Cancer Res 67, 3569–3573.
32 Yee Koh M, Spivak-Kroizman TR & Powis G (2008) HIF-1 regulation: not so easy come, easy go. Trends Biochem Sci 33, 526–534.
33 Ji Y & Morris ME (2003) Determination of phenethyl isothiocyanate in human plasma and urine by ammonia derivatization and liquid chromatography–tandem mass spectrometry. Anal Biochem 323, 39–47.
34 Hecht SS, Carmella SG & Murphy SE (1999) Effects of watercress consumption on urinary metabolites of nicotine in smokers. Cancer Epidemiol Biomarkers Prev 8, 907–913.
35 Hecht SS, Chung FL, Richie JP, et al. (1995) Effects of watercress consumption on metabolism of a tobacco-specific lung carcinogen in smokers. Cancer Epidemiol Biomarkers Prev 4, 877–884.
36 Gill CI, Haldar S, Boyd LA, et al. (2007) Watercress supplementation in diet reduces lymphocyte DNA damage and alters blood antioxidant status in healthy adults. Am J Clin Nutr 85, 504–510.
37 Hofmann T, Kuhnert A, Schubert A, et al. (2009) Modulation of detoxification enzymes by watercress: in vitro and in vivo investigations in human peripheral blood cells. Eur J Nutr 48, 483–491.
38 Krutzik PO, Irish JM, Nolan GP, et al. (2004) Analysis of protein phosphorylation and cellular signaling events by flow cytometry: techniques and clinical applications. Clin Immunol 110, 206–221.
39 McNaughton SA & Marks GC (2003) Development of a food composition database for the estimation of dietary intakes of glucosinolates, the biologically active constituents of cruciferous vegetables. Br J Nutr 90, 687–697.
40 World Health Organization (2003) Diet, Nutrition and the Prevention of Chronic Diseases. Joint WHO/FAO Expert Consultation. WHO Technical Report Series no. 916. Geneva: WHO.
42 Proud CG (2007) Signalling to translation: how signal transduction pathways control the protein synthetic machinery. Biochem J 403, 217–234.
43 Dames SA, Mulet JM, Rathgeb-Szabo K, et al. (2005) The solution structure of the FATC domain of the protein kinase target of rapamycin suggests a role for redox-dependent structural and cellular stability. J Biol Chem 280, 20558–20564.
44 Salmeen A & Barford D (2005) Functions and mechanisms of redox regulation of cysteine-based phosphatases. Antioxid Redox Signal 7, 560–577.
45 Engelen-Eigles G, Holden G, Cohen JD, et al. (2006) The effect of temperature, photoperiod, and light quality on gluconasturtiin concentration in watercress (Nasturtium officinale R. Br.). J Agric Food Chem 54, 328–334.
46 Kopsell DA, Barickman TC, Sams CE, et al. (2007) Influence of nitrogen and sulfur on biomass production and carotenoid and glucosinolate concentrations in watercress (Nasturtium officinale R. Br.). J Agric Food Chem 55, 10628–10634.
47 Estrela JM, Ortega A & Obrador E (2006) Glutathione in cancer biology and therapy. Crit Rev Clin Lab Sci 43, 143–181.